Oral supplementation with propionate is reflected in the serum of healthy individuals
Background: Short-chain fatty acids (SCFAs), including propionic acid (PA), are key in immunological research. Supplementing PA has shown benefits for autoimmune diseases. A comprehensive understanding of the PA pharmacokinetics is essential for the optimal design and execution of studies utilizing...
Saved in:
Main Authors: | Maximilian Schröder, Arijan Pasic, Frank Hirche, Svitlana Rozanova, Melissa Sgodzai, Barbara Gisevius, Lea Horstkemper, Ralf Gold, Katrin Marcus, Kalliopi Pitarokoili, Jeremias Motte, Katalin Barkovits, Gabriele Stangl, Anna Lena Fisse |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/17562864241309755 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Propionate metabolism in Desulfurella acetivorans
by: Eugenio Pettinato, et al.
Published: (2025-02-01) -
Comparison of Once- with Twice-Daily Dosing of Fluticasone Propionate in Mild and Moderate Asthma
by: Louis-Philippe Boulet, et al.
Published: (2000-01-01) -
Fluticasone Propionate in Inflammatory Bowel Disease
by: Marta Carpani de Kaski, et al.
Published: (1990-01-01) -
The Protective Effect of Docosahexaenoic Acid on Mitochondria in SH-SY5Y Model of Rotenone-Induced Toxicity
by: Britta Eggers, et al.
Published: (2025-01-01) -
Clinical Course and Nutritional Management of Propionic and Methylmalonic Acidemias
by: Amira Mobarak, et al.
Published: (2020-01-01)